FDA-SSN-1233197

This in vitro diagnostic substances, reagents, test kits and sets federal contracting opportunity for Office of Finance, Budget and Acquisitions, Health and Human Services, provides in-vitro diagnostic substance manufacturing products and/or services. The original notice was posted on August 05, 2020 and last updated August 05, 2020 with a response date of August 14, 2020.

Most recently (August 05, 2020), the sources sought notice, solicitation number was changed, response date was moved to Aug 14, 2020, buying agency was changed, place of performance was updated to MD 20993, USA, industry classification was changed, product/service classification was updated, contracting officer contact information was updated, and description was updated.

The civilian buyer (Office of Finance, Budget, Acquisitions, and Planning) from Health and Human Services spent $1.9B in federal contracting dollars in fiscal year 2023 with a stable budget forecast heading into FY24. Office of Finance, Budget, Acquisitions, and Planning shows unrestricted competition preference with 13.95% in set aside dollars (versus full and open competiton).

Read the full report

Contracting Agency/Office

HEALTH AND HUMAN SERVICES, DEPARTMENT OF/FOOD AND DRUG ADMINISTRATION/FDA OFFICE OF ACQ GRANT SVCS
Human primary CD34+ Hematopoietic stem and Progenitor cells

Place of Performance

MD 20993, USA

Read the full report